CongressBuys

Sen. John Boozman sold Gilead Sciences (GILD)

Sen. John Boozman (R-AR) · $1K–$15K · traded Apr 16, 2025

Transaction
Sold (full)
Amount
$1K–$15K
Owner
Joint
Traded
Apr 16, 2025
Disclosed
May 14, 2025
Days to disclose
28
Asset type
Stock
As filed
Gilead Sciences Inc
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

Recent Congress trades in GILD

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.